AU2001240998A1 - Method of and kit for assessing responsiveness of cancer patients to antifolate chemotherapy - Google Patents

Method of and kit for assessing responsiveness of cancer patients to antifolate chemotherapy

Info

Publication number
AU2001240998A1
AU2001240998A1 AU2001240998A AU4099801A AU2001240998A1 AU 2001240998 A1 AU2001240998 A1 AU 2001240998A1 AU 2001240998 A AU2001240998 A AU 2001240998A AU 4099801 A AU4099801 A AU 4099801A AU 2001240998 A1 AU2001240998 A1 AU 2001240998A1
Authority
AU
Australia
Prior art keywords
kit
cancer patients
assessing responsiveness
antifolate
chemotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001240998A
Other languages
English (en)
Inventor
Yehuda Assaraf
Statvit Drori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technion Research and Development Foundation Ltd
Original Assignee
Technion Research and Development Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technion Research and Development Foundation Ltd filed Critical Technion Research and Development Foundation Ltd
Publication of AU2001240998A1 publication Critical patent/AU2001240998A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001240998A 2000-03-06 2001-03-06 Method of and kit for assessing responsiveness of cancer patients to antifolate chemotherapy Abandoned AU2001240998A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51967300A 2000-03-06 2000-03-06
US09519673 2000-03-06
PCT/IL2001/000212 WO2001065994A2 (fr) 2000-03-06 2001-03-06 Methode et materiel d'evaluation de la faculte de reponse de patients cancereux a une chimiotherapie a antifolate

Publications (1)

Publication Number Publication Date
AU2001240998A1 true AU2001240998A1 (en) 2001-09-17

Family

ID=24069301

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001240998A Abandoned AU2001240998A1 (en) 2000-03-06 2001-03-06 Method of and kit for assessing responsiveness of cancer patients to antifolate chemotherapy

Country Status (2)

Country Link
AU (1) AU2001240998A1 (fr)
WO (1) WO2001065994A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072722A1 (en) 2002-10-10 2004-04-15 Kornblith Paul L. Methods for assessing efficacy of chemotherapeutic agents
US20040023375A1 (en) 2002-07-30 2004-02-05 Precision Therapeutics, Inc. Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
US7582282B2 (en) 2003-08-29 2009-09-01 Prometheus Laboratories Inc. Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
US20110229892A1 (en) * 2008-11-17 2011-09-22 Yehuda G Assaraf Method for predicting a patient's responsiveness to anti-folate therapy
WO2011005504A1 (fr) * 2009-06-22 2011-01-13 Precision Therapeutics, Inc. Procédés de prédiction d'une réponse d'un patient atteint de cancer à une thérapie aux antifolates

Also Published As

Publication number Publication date
WO2001065994A3 (fr) 2002-01-17
WO2001065994A2 (fr) 2001-09-13

Similar Documents

Publication Publication Date Title
AU2002213485A1 (en) Inhibitors of protein kinases
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003280188A1 (en) Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
IL161921A0 (en) 3-Cyanoquinolines as inhibitors of egf-r and her2 kinases
IL154016A0 (en) Pyrazole derivatives and their use as protein kinase inhibitors
AU2728201A (en) 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
AU2003273542A1 (en) Methods of identifying and isolating stem cells and cancer stem cells
AU2001232036A1 (en) Pyrimidine derivatives as selective inhibitors of cox-2
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2002226911A1 (en) Indol derivative and their use as inhibitors of p38 kinase
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
MXPA03009257A (es) Derivados de isoxaxol como inhibidores de src y otras proteinas cinasas.
AU2003210983A1 (en) Kinase inhibitors and methods of use thereof
AU2001240998A1 (en) Method of and kit for assessing responsiveness of cancer patients to antifolate chemotherapy
AU2001255796A1 (en) (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
AU2001255696A1 (en) Telomerase inhibitors and methods of their use
AU4150999A (en) Method and kit for early diagnosis of cancer
AU2002237662A1 (en) Analysis of soluble factor biological markers
AU2001251702A1 (en) Personal drug testing kit
AU2001296448A1 (en) Tumor marker and methods of use
AU2001292468A1 (en) Methods and means of rna analysis
AU2002306845A1 (en) Telomerase inhibitors and methods of their use